Post-earnings recap
Reported
Fri, Oct 23, 2009
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
0%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Dr. Reddy's Laboratories reported an earnings per share of $0.27, exceeding expectations by 33.50%. The stock reacted positively, rising by 3.71%. However, there was no revenue figure disclosed, and no guidance was provided for future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.27 | N/A | +33.50% |
| Revenue | N/A | N/A | N/A |
No transcript is on record for this earnings call, so the analysis is based solely on the numerical results.